Forschung & Innovation
Publikationen
Dosing considerations for rufinamide in patients with Lennox-Gastaut syndrome: Phase III trial results and real-world clinical data.
PMU Autor*in
Gerhard Kluger
Alle Autor*innen
Sanjeev Kothare, Gerhard Kluger, Rajesh Sachdeo, Betsy Williams, Omar Olhaye, Carlos Perdomo, Francesco Bibbiani
Fachzeitschrift
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
Kurzfassung
Keywords
PLACEBO-CONTROLLED TRIAL, DOUBLE-BLIND, EXPERIENCE, LONG-TERM, CHILDREN, EFFICACY, OPEN-LABEL, SEIZURES, PEDIATRIC EPILEPSY, ADJUNCTIVE THERAPY